title: Association of hormonal contraception and HIV-seroprevalence in Nairobi, Kenya.
abstract: Among women attending family planning clinics in Nairobi, Kenya, the HIV-seroprevalence rates for different contraceptive methods were: depomedroxyprogesterone acetate (DMPA) 431/3279 (13.1%), combination oral contraceptive pill 114/1073 (10.6%), and progesterone-only contraceptive pill (POCP) 45/741 (6.1%). After adjusting for age, marital status, and parity, women using the POCP had a lower HIV seroprevalence (adjusted odds ratio 0.5, 95% confidence interval 0.3-0.7) than women using DMPA. This association was most pronounced among POCP users of lower parity.
authors.affiliation: Department of Obstetrics and Gynecology, University of Washington, Seattle, USA.
authors.forename: Amy
authors.initials: A
authors.lastname: Criniti
authors.forename: Christina W
authors.initials: CW
authors.lastname: Mwachari
authors.forename: Amalia S
authors.initials: AS
authors.lastname: Meier
authors.forename: Videlis
authors.initials: V
authors.lastname: Nduba
authors.forename: Lucy
authors.initials: L
authors.lastname: Sanguli
authors.forename: James K
authors.initials: JK
authors.lastname: Ngumo
authors.forename: Craig R
authors.initials: CR
authors.lastname: Cohen
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D018791:CD4 Lymphocyte Count; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use; D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use*; D004198:Disease Susceptibility; D005260:Female; D006679:HIV Seropositivity / Q000453:epidemiology*; D006801:Humans; D007630:Kenya / Q000453:epidemiology; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D010298:Parity; D011374:Progesterone / Q000627:therapeutic use*; D016036:Seroepidemiologic Studies
chemical_list: D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D011374:Progesterone; D017258:Medroxyprogesterone Acetate